HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Georg Nollert Bruno Reichart Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nollert, G. Articles by Reichart, B. Search for Related Content PubMed PubMed Citation Articles by Nollert, G. Articles by Reichart, B.

J Thorac Cardiovasc Surg 2003;126:965-968
© 2003 The American Association for Thoracic Surgery

Surgery for acquired cardiovascular disease

Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement

^a Department of Cardiac Surgery, University of Munich, Munich, Germany

Received for publication July 26, 2002; revisions received October 8, 2002; accepted for publication October 28, 2002.

^* Address for reprints: Georg Nollert, MD, Department of Cardiac Surgery, Klinikum Grosshadern, Marchioninistr. 15, 81366 Munich, Germany
gnollert{at}t-online.de

BACKGROUND:: Recent studies have demonstrated the influence of atherosclerotic risk factors on the progression of aortic stenosis. We hypothesized that risk factors for atherosclerosis might also be involved in the degeneration of pericardial heart valves and might lead to reoperation as a result of structural valve failure, especially in younger patients with high degeneration rates.

METHODS: In 1984 and 1985, 161 patients (74% male; mean age, 54.4 ± 1.0 years; age range, 17-76 years; median age, 56.5 years) survived isolated aortic (n = 137) or combined aortic and mitral (n = 25) valve replacement with a Hancock extracorporeal pericardial valve. Of these patients, 90 (56%) had reoperations as a result of tissue failure of the aortic valve 5.6 ± 0.25 years postoperatively.

RESULTS: The patient group was split in half at the median age. In patients aged 57 years or younger, diabetes mellitus, female sex, cigarette smoking, and high cholesterol and triglyceride levels were associated with accelerated valve failure. In a multivariate model sex (female, P = .001), smoking (P = .001), diabetes mellitus (P = .020), and cholesterol levels (P = .011) are risk factors for reoperation. Patients without risk factors had reoperation after a mean of 9.25 ± 0.88 years compared with 4.05 ± 0.43 years (P = .0002) in patients with 2 or 3 risk factors.

CONCLUSIONS: Risk factors of atherosclerosis might play a substantial role in the degeneration of aortic bioprosthetic valves. Lowering of serum lipid levels, smoking cessation, therapy for diabetes, and careful patient selection could be new strategies to postpone degeneration. Younger patients could then possibly benefit from the advantages of bioprostheses.

This article has been cited by other articles:

				C. A. Yankah, M. Pasic, M. Musci, J. Stein, C. Detschades, H. Siniawski, and R. Hetzer Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 688 - 696. [Abstract] [Full Text] [PDF]

				M. Briand, P. Pibarot, J.-P. Despres, P. Voisine, J. G. Dumesnil, F. Dagenais, and P. Mathieu Metabolic Syndrome Is Associated With Faster Degeneration of Bioprosthetic Valves Circulation, July 4, 2006; 114(1_suppl): I-512 - I-517. [Abstract] [Full Text] [PDF]

				O. A. Khan, R. Chau, C. Bertram, M. A. Hanson, and S. K. Ohri Fetal origins of coronary heart disease--implications for cardiothoracic surgery? Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1036 - 1042. [Abstract] [Full Text] [PDF]